I was waiting for the first person to say this, which is why I explicitly wrote "black" when describing the disproportionate rates of sickle cell in black children vs. white children. This isn't some rhetorical game. We know what "race" is, intuitively, and we
know that it correlates strongly with real-world biological outcomes.
These guidelines are gaslighting people into ignoring broadly useful categories because we don't have a reductive way of defining them. We don't have a biological test that defines race (yet), ergo, it doesn't exist. Except that's wrong. It's absurd.
> In studies of conditions like sickle cell anaemia or lactose intolerance or skin cancer it would probably be more useful to relate those to particular genotypes and/or phenotypes rather than relying on which "race" field each experimental subject selected on the intake form.
If we could do that -- relate the (known) gene for sickle cell to some other "genotype" that captures the racial bias we know exists -- we'd have a strict biological definition for race, wouldn't we?
Aside from that, we know the "phenotype" that correlates with the illness. Black people have it, at high rates.